ORASURE TECHNOLOGIES INC. - COMMON STOCK

U.S. FDA Authorizes InteliSwab™ COVID-19 Rapid Tests for OTC Single-Use, At-Home Testing for Symptomatic People and Accepts Data for Delta Variant Detection

02 Nov 2021 06:05:00 By Nasdaq GlobeNewswire

OraSure Technologies 2021 Third Quarter Earnings Conference Call Wednesday, November 3, 2021, 5:00 p.m. ET

27 Oct 2021 06:05:00 By Nasdaq GlobeNewswire

OraSure Awarded $109 Million Contract from U.S. Department of Defense to Ramp Manufacturing of InteliSwab™ COVID-19 Rapid Test

04 Oct 2021 06:05:00 By Nasdaq GlobeNewswire

OraSure to Receive up to $13.6 Million from Biomedical Advanced Research Development Authority to Support InteliSwab™ COVID-19 Rapid Test 510(k) Clearance and CLIA Waiver

23 Sep 2021 07:10:00 By Nasdaq GlobeNewswire

OraSure Receives $205 Million Procurement Contract for InteliSwab™ from the Defense Logistics Agency to Supply Over-the-Counter (OTC) Kits as Part of National Pandemic Response

20 Sep 2021 05:00:00 By Nasdaq GlobeNewswire

OraSure Technologies Announces Resignation of CFO Roberto Cuca and Succession Plan

02 Sep 2021 06:00:01 By Nasdaq GlobeNewswire

OraSure Technologies Reports 2Q21 Revenue of $57.6 Million Driven by Strong Rebound in Core Business

03 Aug 2021 15:05:01 By Nasdaq GlobeNewswire

OraSure Technologies, Inc. to Hold 2021 Second Quarter Earnings Conference Call Tuesday, August 3, 2021, 5:00 p.m. ET

27 Jul 2021 15:01:00 By Nasdaq GlobeNewswire

OraSure Technologies to Present at the Raymond James 2021 Human Health and Innovation Conference

17 Jun 2021 15:05:00 By Nasdaq GlobeNewswire

OraSure and the Will Rodgers Liver Health Foundation to Heighten Awareness Around the Importance of Hepatitis C Testing

14 Jun 2021 05:00:00 By Nasdaq GlobeNewswire

OraSure Technologies Receives Three Emergency Use Authorizations for its COVID-19 Rapid Antigen Tests for Non-Prescription (OTC), Professional and Prescription Use

07 Jun 2021 08:18:15 By Nasdaq GlobeNewswire

OraSure Technologies to Present at the Jefferies Virtual Healthcare Conference

28 May 2021 06:00:00 By Nasdaq GlobeNewswire

OraSure Technologies to Present at the UBS Global Healthcare Virtual Conference

18 May 2021 06:00:00 By Nasdaq GlobeNewswire

OraSure Technologies Appoints Scott Gleason As Senior Vice President Investor Relations and Corporate Communications

17 May 2021 06:00:01 By Nasdaq GlobeNewswire

OraSure Technologies to Hold Virtual Annual Meeting of Stockholders on May 18, 2021

12 May 2021 05:00:00 By Nasdaq GlobeNewswire

Insignia and Partners Support CDC Demonstration Project for Uptake of Self-test Kits for HIV

10 May 2021 05:00:00 By Nasdaq GlobeNewswire

OraSure Technologies, Inc. Announces First Quarter 2021 Financial Results and Provides COVID-19 Update

05 May 2021 15:00:00 By Nasdaq GlobeNewswire

OraSure Technologies to Hold 2021 First Quarter Earnings Conference Call Wednesday, May 5, 2021, 5:00 p.m. ET

30 Apr 2021 15:01:00 By Nasdaq GlobeNewswire

OraSure Technologies Submits COVID-19 Rapid Antigen Prescription Home Self-Test and Professional Test to FDA for Emergency Use Authorization

30 Mar 2021 06:00:00 By Nasdaq GlobeNewswire

OraSure Technologies, Inc. Announces 2020 Full-Year and Fourth Quarter Financial Results and Provides COVID-19 Update

01 Mar 2021 15:15:00 By Nasdaq GlobeNewswire